A look into the future: improving diabetes care by 2015

References

• van Avendonk MJ, Gorter KJ, van den Donk M, et al. Insulin therapy in type 2 diabetes is no longer a secondary care activity in the Netherlands. Prim Care Diabetes 2009;3:23-8
   PubMedGoogle Scholar
• Goyder EC, McNally PG, Drucquer M, et al. Shifting of care for diabetes from secondary to primary care, 1990–5: review of general practices. BMJ 1998;316:1505-6
   PubMed Web of Science ®Google Scholar
• Khunti K, Ganguli S. Who looks after people with diabetes: primary or secondary care? J R Soc Med 2000;93:183-6
   PubMed Web of Science ®Google Scholar
• Brunton S, Carmichael B, Funnell M, et al. Type 2 diabetes: the role of insulin. J Fam Pract 2005;54:445-52
   PubMed Web of Science ®Google Scholar
• Currie CJ, Gale EA, Poole CD. Estimation of primary care treatment costs and treatment efficacy for people with Type 1 and Type 2 diabetes in the United Kingdom from 1997 to 2007. Diabet Med 2010;27:938-48
   PubMed Web of Science ®Google Scholar
• Dale J, Martin S, Gadsby R. Insulin initiation in primary care for patients with type 2 diabetes: 3-year follow-up study. Prim Care Diabetes 2010;4:85-9
   PubMed Web of Science ®Google Scholar
• McCrate F, Godwin M, Murphy L. Attainment of Canadian Diabetes Association recommended targets in patients with type 2 diabetes: a study of primary care practices in St John's, Nfld. Can Fam Physician 2010;56:e13-e19
   PubMed Web of Science ®Google Scholar
• Kunt T, Snoek FJ. Barriers to insulin initiation and intensification and how to overcome them. Int J Clin Pract Suppl 2009;164:6-10
   PubMedGoogle Scholar
• Polonsky WH, Fisher L, Guzman S, et al. Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care 2005;28:2543-5
   PubMed Web of Science ®Google Scholar
• Peyrot M, Rubin RR, Lauritzen T, et al. Psychosocial problems and barriers to improved diabetes management: results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study. Diabet Med 2005;22:1379-85
   PubMed Web of Science ®Google Scholar
• Greaves CJ, Brown P, Terry RT, et al. Converting to insulin in primary care: an exploration of the needs of practice nurses. J Adv Nurs 2003;42:487-96
   PubMed Web of Science ®Google Scholar
• Burke JP, Williams K, Gaskill SP, et al. Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study. Arch Intern Med 1999;159:1450-6
   PubMed Web of Science ®Google Scholar
• Fox CS, Pencina MJ, Meigs JB, et al. Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study. Circulation 2006;113:2914-18
   PubMed Web of Science ®Google Scholar
• Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53
   PubMed Web of Science ®Google Scholar
• Hsiao CJ, Cherry DK, Beatty PC, et al. National Ambulatory Medical Care Survey: 2007 Summary. National Health Statistics Reports 2010;27:1-32
   PubMedGoogle Scholar
• Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988–2006. Diabetes Care 2010;33:562-8
   Google Scholar
• National Diabetes Statistics. 2007. Available at: http://diabetes.niddk.nih.gov/dm/pubs/statistics/index.htm [Last accessed 25 February 2011].
   Google Scholar
• Cherry D, Lucas C, Decker SL. Population Aging and the Use of Office-based Physician Services. NCHS Data Brief. Centers for Disease Control and Prevention (CDC) published August 2010. http://www.cdc.gov/nchs/data/databriefs/db41.pdf
   Google Scholar
• Hoerger TJ, Segel JE, Gregg EW, et al. Is glycemic control improving in U.S. adults?. Diabetes Care 2008;31:81-6
   PubMed Web of Science ®Google Scholar
• Dodd AH, Colby MS, Boye KS, et al. Treatment approach and HbA1c control among US adults with type 2 diabetes: NHANES 1999–2004. Curr Med Res Opin 2009;25:1605-13
   PubMed Web of Science ®Google Scholar
• Harris SB, Ekoe JM, Zdanowicz Y, et al. Glycemic control and morbidity in the Canadian primary care setting (results of the diabetes in Canada evaluation study). Diabetes Res Clin Pract 2005;70:90-7
   PubMed Web of Science ®Google Scholar
• Fox KM, Gerber Pharmd RA, Bolinder B, et al. Prevalence of inadequate glycemic control among patients with type 2 diabetes in the United Kingdom general practice research database: a series of retrospective analyses of data from 1998 through 2002. Clin Ther 2006;28:388-95
   PubMed Web of Science ®Google Scholar
• Nelson KM, Boyko EJ, Koepsell T. All-cause mortality risk among a national sample of individuals with diabetes. Diabetes Care 2010;33:2360-4
   PubMed Web of Science ®Google Scholar
• International Diabetes Federation. Diabetes Atlas. 2011. Available at: http://da3.diabetesatlas.org/index3eec.html [Last accessed 25 February 2010]
   Google Scholar
• Calvert MJ, McManus RJ, Freemantle N. Management of type 2 diabetes with multiple oral hypoglycaemic agents or insulin in primary care: retrospective cohort study. Br J Gen Pract 2007;57:455-60
   PubMed Web of Science ®Google Scholar
• Davis TM, Davis Cyllene Uwa Edu Au WA, Bruce DG. Glycaemic levels triggering intensification of therapy in type 2 diabetes in the community: the Fremantle Diabetes Study. Med J Aust 2006;184:325-8
   PubMed Web of Science ®Google Scholar
• Ringborg A, Lindgren P, Yin DD, et al. Time to insulin treatment and factors associated with insulin prescription in Swedish patients with type 2 diabetes. Diabetes Metab 2010;36:198-203
   PubMed Web of Science ®Google Scholar
• Rubino A, McQuay LJ, Gough SC, et al. Delayed initiation of subcutaneous insulin therapy after failure of oral glucose-lowering agents in patients with Type 2 diabetes: a population-based analysis in the UK. Diabet Med 2007;24:1412-18
   PubMed Web of Science ®Google Scholar
• Simons WR, Vinod HD, Gerber RA, et al. Does rapid transition to insulin therapy in subjects with newly diagnosed type 2 diabetes mellitus benefit glycaemic control and diabetes-related complications? A German population-based study. Exp Clin Endocrinol Diabetes 2006;114:520-6
   PubMed Web of Science ®Google Scholar
• Zafar A, Davies M, Azhar A, et al. Clinical inertia in management of T2DM. Prim Care Diabetes 2010;4:203-7
   PubMed Web of Science ®Google Scholar
• Ziemer DC, Miller CD, Rhee MK, et al. Clinical inertia contributes to poor diabetes control in a primary care setting. Diabetes Educ 2005;31:564-71
   PubMed Web of Science ®Google Scholar
• Hsu WC. Consequences of delaying progression to optimal therapy in patients with type 2 diabetes not achieving glycemic goals. South Med J 2009;102:67-76
   PubMed Web of Science ®Google Scholar
• Swinnen SG, Devries JH. Contact frequency determines outcome of basal insulin initiation trials in type 2 diabetes. Diabetologia 2009;52:2324-7
   PubMed Web of Science ®Google Scholar
• Frid A, Hirsch L, Gaspar R, et al. New injection recommendations for patients with diabetes. Diabetes Metab 2010;36(Suppl 1):S3-18
   PubMed Web of Science ®Google Scholar
• Rodbard HW, Jellinger PS, Davidson JA, et al. Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. Endocr Pract 2009;15:540-59
   PubMed Web of Science ®Google Scholar
• CG87 – Type 2 Diabetes – Newer Agents. Royal College of Physicians, 2009
   Google Scholar
• Global Guideline for Type 2 Diabetes. International Diabetes Federation, 2005
   Google Scholar
• Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Canadian Diabetes Association, 2008
   Google Scholar
• Woo V. Important differences: Canadian Diabetes Association 2008 clinical practice guidelines and the consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2009;52:552-3
   PubMed Web of Science ®Google Scholar
• Monami M, Marchionni N, Mannucci E. Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a meta-analysis. Diabetes Res Clin Pract 2008;81:184-9
   PubMed Web of Science ®Google Scholar
• Alvarez GF, Mavros P, Nocea G, et al. Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) study. Diabetes Obes Metab 2008;10(Suppl 1):8-15
   PubMedGoogle Scholar
• Fu AZ, Qiu Y, Davies MJ, et al. Treatment intensification in patients with type 2 diabetes who failed metformin monotherapy. Diabetes Obes Metab 2011;13:765-9
   PubMed Web of Science ®Google Scholar
• Loveman E, Frampton GK, Clegg AJ. The clinical effectiveness of diabetes education models for Type 2 diabetes: a systematic review. Health Technol Assess 2008;12:1-116,iii
   Web of Science ®Google Scholar
• Stroebel RJ, Gloor B, Freytag S, et al. Adapting the chronic care model to treat chronic illness at a free medical clinic. J Health Care Poor Underserved 2005;16:286-96
   PubMed Web of Science ®Google Scholar
• Rhee MK, Slocum W, Ziemer DC, et al. Patient adherence improves glycemic control. Diabetes Educ 2005;31:240-50
   PubMed Web of Science ®Google Scholar
• Donnelly LA, Morris AD, Evans JM. Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes. QJM 2007;100:345-50
   PubMed Web of Science ®Google Scholar
• Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care 2004;27:1218-24
   PubMed Web of Science ®Google Scholar
• Peyrot M, Rubin RR, Kruger DF, et al. Correlates of insulin injection omission. Diabetes Care 2010;33:240-5
   PubMed Web of Science ®Google Scholar
• Pollack MF, Purayidathil FW, Bolge SC, et al. Patient-reported tolerability issues with oral antidiabetic agents: Associations with adherence; treatment satisfaction and health-related quality of life. Diabetes Res Clin Pract 2010;87:204-10
   PubMed Web of Science ®Google Scholar
• Rubin RR. Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus. Am J Med 2005;118(Suppl 5A):27S-34S
   PubMed Web of Science ®Google Scholar
• Devries JH, Nattrass M, Pieber TR. Refining basal insulin therapy: what have we learned in the age of analogues? Diabetes Metab Res Rev 2007;23:441-54
   PubMed Web of Science ®Google Scholar
• Data on file. The Global Attitudes of Patients and Physicians in Insulin Therapy (GAPP) survey. 17-11-2010
   Google Scholar
• Blonde L, Merilainen M, Karwe V, et al. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets – the TITRATE study. Diabetes Obes Metab 2009;11:623-31
   PubMed Web of Science ®Google Scholar
• Meneghini L, Koenen C, Weng W, et al. The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes – results of the randomized, controlled PREDICTIVE 303 study. Diabetes Obes Metab 2007;9:902-13
   PubMed Web of Science ®Google Scholar
• Davies M, Storms F, Shutler S, et al. Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine. Diabetes Care 2005;28:1282-8
   PubMed Web of Science ®Google Scholar
• Karter AJ, Ackerson LM, Darbinian JA, et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med 2001;111:1-9
   PubMed Web of Science ®Google Scholar
• Choudhary P, Amiel SA. Hypoglycaemia: current management and controversies. Postgrad Med J 2011;87:298-306
   PubMed Web of Science ®Google Scholar
• Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007;50:1140-7
   Google Scholar
• Chelliah A, Burge MR. Hypoglycaemia in elderly patients with diabetes mellitus: causes and strategies for prevention. Drugs Aging 2004;21:511-30
   PubMed Web of Science ®Google Scholar
• Russell ML, Insull W Jr, Probstfield JL. Examination of medical professions for counseling on medication adherence. Am J Med 1985;78:277-82
   PubMed Web of Science ®Google Scholar
• Goderis G, Borgermans L, Grol R, et al. Start improving the quality of care for people with type 2 diabetes through a general practice support program: a cluster randomized trial. Diabetes Res Clin Pract 2010;88:56-64
   PubMed Web of Science ®Google Scholar
• Margeirsdottir HD, Larsen JR, Kummernes SJ, et al. The establishment of a new national network leads to quality improvement in childhood diabetes: implementation of the ISPAD Guidelines. Pediatr Diabetes 2010;11:88-95
   PubMed Web of Science ®Google Scholar
• Kilpatrick ES, Das AK, Orskov C, et al. Good glycaemic control: an international perspective on bridging the gap between theory and practice in type 2 diabetes. Curr Med Res Opin 2008;24:2651-61
   PubMed Web of Science ®Google Scholar
• Sevick MA, Trauth JM, Ling BS, et al. Patients with complex chronic diseases: perspectives on supporting self-management. J Gen Intern Med 2007;22(Suppl 3):438-44
   PubMedGoogle Scholar
• Aschner P, LaSalle J, McGill M. The team approach to diabetes management: partnering with patients. Int J Clin Pract Suppl 2007;157:22-30
   PubMedGoogle Scholar
• Serrano-Gil M, Jacob S. Engaging and empowering patients to manage their type 2 diabetes, Part I: a knowledge, attitude, and practice gap? Adv Ther 2010;27:321-33
   PubMed Web of Science ®Google Scholar
• Cochran J, Conn VS. Meta-analysis of quality of life outcomes following diabetes self-management training. Diabetes Educ 2008;34:815-23
   PubMed Web of Science ®Google Scholar
• Edwall LL, Danielson E, Ohrn I. The meaning of a consultation with the diabetes nurse specialist. Scand J Caring Sci 2010;24:341-8
   PubMed Web of Science ®Google Scholar
• Hood KK, Rohan JM, Peterson CM, et al. Interventions with adherence-promoting components in pediatric type 1 diabetes: meta-analysis of their impact on glycemic control. Diabetes Care 2010;33:1658-64
   PubMed Web of Science ®Google Scholar
• Parkin T, Skinner TC. Discrepancies between patient and professionals recall and perception of an outpatient consultation. Diabet Med 2003;20:909-14
   PubMed Web of Science ®Google Scholar
• van Bastelaar KM, Pouwer F, Cuijpers P, et al. Web-based depression treatment for type 1 and type 2 diabetic patients: a randomized, controlled trial. Diabetes Care 2011;34:320-5
   PubMed Web of Science ®Google Scholar
• Rothenbacher D, Ruter G, Brenner H. Prognostic value of physicians' assessment of compliance regarding all-cause mortality in patients with type 2 diabetes: primary care follow-up study. BMC Fam Pract 2006;7:42
   PubMedGoogle Scholar
• Wartman SA, Morlock LL, Malitz FE, et al. Patient understanding and satisfaction as predictors of compliance. Med Care 1983;21:886-91
   PubMed Web of Science ®Google Scholar
• Hardy KJ, O'Brien SV, Furlong NJ. Information given to patients before appointments and its effect on non-attendance rate. BMJ 2001;323:1298-300
   PubMed Web of Science ®Google Scholar
• Berben L, Bogert L, Leventhal ME, et al. Which interventions are used by health care professionals to enhance medication adherence in cardiovascular patients? A survey of current clinical practice. Eur J Cardiovasc Nurs 2010;10:14-21
   PubMed Web of Science ®Google Scholar
• van Dulmen S, Sluijs E, van Dijk L, et al. Furthering patient adherence: a position paper of the international expert forum on patient adherence based on an internet forum discussion. BMC Health Serv Res 2008;8:47
   PubMed Web of Science ®Google Scholar
• Hughes CM. Medication non-adherence in the elderly: how big is the problem? Drugs Aging 2004;21:793-811
   PubMed Web of Science ®Google Scholar
• Haynes RB, Ackloo E, Sahota N, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2008;2:CD000011
   PubMed Web of Science ®Google Scholar
• Chapman RH, Kowal SL, Cherry SB, et al. The modeled lifetime cost-effectiveness of published adherence-improving interventions for antihypertensive and lipid-lowering medications. Value Health 2010;13:685-94
   PubMed Web of Science ®Google Scholar
• McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA 2002;288:2868-79
   PubMed Web of Science ®Google Scholar
• Jansink R, Braspenning J, van der Weijden T, et al. Primary care nurses struggle with lifestyle counseling in diabetes care: a qualitative analysis. BMC Fam Pract 2010;11:41
   PubMed Web of Science ®Google Scholar